Brady Sillman
5PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 21, 2026
An ultra-long-acting dimeric bictegravir prodrug defined by a short pharmacokinetic tail.Mohammad Ullah Nayan, Brady Sillman, Srijanee Das
|Mar 04, 2025
An Ultra-Long-Acting Dimeric Bictegravir Prodrug Defined by a Short Pharmacokinetic Tail.Benson Edagwa, Mohammad Ullah Nayan, Brady Sillman
|May 01, 2023
CRISPR editing of CCR5 and HIV-1 facilitates viral elimination in antiretroviral drug-suppressed virus-infected humanized mice.Prasanta K Dash, Chen Chen, Rafal Kaminski
|Jun 10, 2022
Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation.Suyash Deodhar, Brady Sillman, Aditya N Bade
|Jun 09, 2021
Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir.Nagsen Gautam, JoEllyn M McMillan, Devendra Kumar
Pageof 1
Frequent Collaborators
5 joint publications
Howard Gendelman
4 joint publications
Benson J Edagwa
3 joint publications
Samuel M Cohen
2 joint publications
Ashrafi Sultana
2 joint publications
Prasanta K Dash
2 joint publications
Srijanee Das
2 joint publications
Chen Zhang
1 joint publications
Brandon W Hanson
1 joint publications
Sean N Avedissian
1 joint publications
Milica Markovic
